Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate
- PMID: 17364311
- DOI: 10.1080/00016340601134598
Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate
Abstract
Background: Vaginal administration of prostaglandin analogues as well as nitric oxide donors before first-trimester surgical abortion has been shown to induce effective cervical ripening. In addition, nitric oxide donors, such as isosorbide mononitrate and nitroglycerin, have been associated with a patient-friendly side-effect profile when administered 3 h before the surgical procedure. We wanted to compare the cervical ripening effect and possible side effects of isosorbide mononitrate and the prostaglandin analogue misoprostol when self-administered at bedtime the evening before surgical abortion.
Methods: One hundred and twenty nulliparous women scheduled for suction termination of pregnancy in the first trimester were randomly assigned to receive per vaginam either 40 mg of isosorbide mononitrate or 200 microg of misoprostol. Sixty of the women were included for assessment of cervical ripening as well as evaluation of side effects. The other 60 women were recruited for assessment of side effects only. Cervical ripening was evaluated by measuring baseline cervical dilation and the cumulative force to dilate the cervix to 9 mm by means of a cervical tonometer. For assessment of side effects, the women were asked to complete a symptom questionnaire.
Results: Cervical resistance was significantly higher in women treated with isosorbide mononitrate compared to misoprostol (median cumulative force 73 versus 15 N). Common side effects of misoprostol were abdominal pain (69%), nausea (44%), and vaginal bleeding (66%), while in the isosorbide mononitrate group headache was frequently experienced (79%). In both treatment groups, the frequency and intensity of side effects gradually increased during the treatment interval.
Conclusions: Misoprostol induced a more pronounced cervical ripening than isosorbide mononitrate, but both regimens were associated with a high frequency of side effects.
Similar articles
-
Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.Lancet. 1998 Oct 3;352(9134):1093-6. doi: 10.1016/S0140-6736(98)01289-6. Lancet. 1998. PMID: 9798584 Clinical Trial.
-
A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening: a randomised controlled trial.BJOG. 2001 Mar;108(3):276-80. doi: 10.1111/j.1471-0528.2001.00041.x. BJOG. 2001. PMID: 11281468 Clinical Trial.
-
A comparison of isosorbide mononitrate and misoprostol cervical ripening before suction evacuation.Obstet Gynecol. 2003 Sep;102(3):583-8. doi: 10.1016/s0029-7844(03)00514-3. Obstet Gynecol. 2003. PMID: 12962946 Clinical Trial.
-
Efficacy and safety of isosorbide mononitrate plus misoprostol compared to misoprostol alone in the management of the first and second trimester abortion: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2024 Jun 10;24(1):419. doi: 10.1186/s12884-024-06614-9. BMC Pregnancy Childbirth. 2024. PMID: 38858628 Free PMC article.
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
Cited by
-
Nitric oxide donors for cervical ripening in first-trimester surgical abortion.Cochrane Database Syst Rev. 2015 Feb 25;2015(2):CD007444. doi: 10.1002/14651858.CD007444.pub4. Cochrane Database Syst Rev. 2015. PMID: 25927092 Free PMC article.
-
Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins.J Transl Med. 2012 Mar 7;10:40. doi: 10.1186/1479-5876-10-40. J Transl Med. 2012. PMID: 22397627 Free PMC article. Clinical Trial.
-
Evaluation of nitric acid donor, transdermal glycerol trinitrate patches for facilitating cervical ripening: a randomised controlled trial.Arch Gynecol Obstet. 2024 Jun;309(6):2653-2661. doi: 10.1007/s00404-023-07180-9. Epub 2023 Aug 31. Arch Gynecol Obstet. 2024. PMID: 37653250 Clinical Trial.
-
Evaluation of isosorbide-5-mononitrate as a cervical ripening agent prior to induced abortion in contrast to misoprostol- a randomized controlled trial.Obstet Gynecol Sci. 2019 Sep;62(5):313-321. doi: 10.5468/ogs.2019.62.5.313. Epub 2019 Aug 9. Obstet Gynecol Sci. 2019. PMID: 31538074 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical